Suppression of FUT1/FUT4 expression by siRNA inhibits tumor growth

Area of Science:

• Oncology
• Glycobiology
• Molecular Biology

Background:

• Lewis Y (LeY) antigen is prevalent in epithelial cell-derived carcinomas.
• Targeting LeY offers a potential therapeutic strategy for cancer treatment.
• The impact of genetically suppressing LeY expression on cancer proliferation remains largely unexplored.

Purpose of the Study:

• To investigate the role of fucosyltransferases (FUTs) in LeY synthesis in human epidermoid carcinoma A431 cells.
• To determine the effect of genetically suppressing FUT1 and FUT4 on LeY expression and cancer cell proliferation.
• To evaluate the therapeutic potential of targeting FUT1/4 for cancer treatment.

Main Methods:

• Utilized short interfering RNA (siRNA) to knock down fucosyltransferase I (FUT1) and fucosyltransferase IV (FUT4) expression in A431 cells.
• Quantified LeY antigen expression and assessed cell proliferation rates.
• Investigated the effects on the epidermal growth factor receptor (EGFR) signaling pathway, including EGFR tyrosine phosphorylation and mitogen-activated protein kinases (MAPKs).
• Evaluated tumor growth in nude mice models following siRNA treatment.

Main Results:

• Knockdown of FUT1/4 significantly reduced FUT1/4 and LeY expression in A431 cells.
• Suppression of FUT1/4 inhibited cancer cell proliferation and impeded tumor growth in vivo.
• Reduced FUT1/4 expression led to decreased EGFR signaling, including blocked EGF-induced tyrosine phosphorylation of EGFR and MAPKs.

Conclusions:

• Suppression of FUT1/4 expression via RNA interference effectively reduces LeY synthesis.
• This strategy inhibits cancer cell proliferation and tumor growth, suggesting a potential therapeutic approach for LeY-expressing cancers.
• Targeting FUT1/4 represents a promising methodology for developing novel cancer therapies.